|
|
|
|
|
|
Science
Kleanthis Xanthopoulus is president and CEO of Carlsbad's Regulus Therapeutics, which is working extensively with RNA-based therapies. Read the whole story here. Photo: Sam Hodgson
Two San Diego companies are betting that jatropha, a poisonous weed, will gain a foothold in the ever more confusing and crowded biofuels market.
» By JONATHAN PARKINSON | Nov 2
Biocom's annual investor conference was not the funereal affair it was last year, but it doesn't look like funders are again ready to take risks on the youngest of start-ups.
|
A group of UCSD researchers are among the leaders in a worldwide effort to understand why honeybees are disappearing at an unprecedented rate. They have honed in on a common pesticide as a possible culprit.
» By REBECCA TOLIN | Nov 8
Big Pharma has largely bailed on the battle against deadly antibiotic-resistant bacteria, leaving the dire public health threat in the hands of small biotechs.
Contributing Voices
Problems at the U.S. Patent Office reverberate in San Diego, as increased costs for patents impact innovation.
» By William E. Hunter | Aug 21
|
Biotech inks deal with Japanese drug maker to develop and market experimental weight loss drugs. Nov. 5 -- 7:09 pm
|
|
|
|
|
|
|
|
Copyright © 2009 voiceofsandiego.org. All Rights Reserved.
|
an independent nonprofit |
Delays in Patent Reform a Detriment to SD Economy
